Navigation Links
University Hospitals Urology Institute Announces Dr. Irina Jaeger Designation as UroLift® Center of Excellence
Date:1/8/2019

University Hospitals Urology Institute today announced that Irina Jaeger, MD, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Jaeger has achieved a high level of training and experience with the UroLift System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with benign prostatic hyperplasia (BPH).

“I’m proud to be recognized as a UroLift Center of Excellence,” Dr. Jaeger said. “The UroLift System can not only better the lives of men suffering from enlarged prostate symptoms, but also improve the lives of their partners. I hear from many spouses who are just as excited about the results of the treatment as their husbands. Unlike most other BPH treatment options, the UroLift System preserves sexual function.”

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial, BPH6, demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy and is superior to TURP at preserving sexual function and offering a more rapid recovery.

Medication is often the first-line therapy for BPH, but relief can be inadequate and temporary. Medication side effects can include sexual dysfunction, dizziness and headaches, prompting many patients to quit taking the medication. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they also can leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

About the UroLift System
NeoTract’s FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About University Hospitals / Cleveland, Ohio

Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 50 outpatient health centers and 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship academic medical center, University Hospitals Cleveland Medical Center, located on a 35-acre campus in Cleveland’s University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development. UH is one of the largest employers in Northeast Ohio with 26,000 employees.

UH’s vision is “Advancing the science of health and the art of compassion,” and its mission: “To Heal. To Teach. To Discover.” Follow UH on Facebook @UniversityHospitals and Twitter @UHhospitals. For more information, go to UHhospitals.org.

# # #

1. Roehrborn et al. Can J. Urology 2017
2. Sonksen et al J Urology 2016

MAC00359-01 Rev C

Read the full story at https://www.prweb.com/releases/university_hospitals_urology_institute_announces_dr_irina_jaeger_designation_as_urolift_center_of_excellence/prweb16016815.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work
2. Yale University Deploys Integration Between its EMR and Fortes OnCore
3. Sorrento Therapeutics and Ben-Gurion University Sign an Agreement for the Development of Anti-Hepatitis C Virus Antibodies
4. Dr. Sheldon Pinnell, The Founding Father Of Topical Antioxidants, Leading Scientist Behind SkinCeuticals, And Chief Emeritus Of The Division Of Dermatology At Duke University, Dies At 76
5. DMC Harper University Hospital Dialysis Access Center Introduces A Safer, Longer-Lasting Approach to "Vascular Graft" Procedure
6. Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University
7. Grifols implementa il suo primo sistema a carosello per la gestione automatizzata dellinventario dei farmaci sperimentali presso la Emory University
8. University of Virginia Cancer Center Begins Using New Telemedicine Technology for Cervical Cancer Screenings
9. Nova Southeastern University Names Lisa Deziel as Dean of the College of Pharmacy
10. Precyse University Offers Mobile Apps for On-Demand ICD-10 Education
11. First of Its Kind Bionic Pain Control Option Offered at The University of Kansas Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... ... June 19, 2019 , ... INDIGO Biosciences, Inc. (INDIGO), ... announced the addition of the Human MDR-1 / P-Glycoprotein Drug Interaction Assay ... and allows researchers to perform critical toxicology testing previously available only through contract ...
(Date:6/18/2019)... ... June 18, 2019 , ... Officials with American Physician ... are pleased to announce the acquisition of Leading Edge Medical Associates (LEMA), a ... physicians and 9 advanced practice clinicians care for 115,000 emergency department patients annually ...
(Date:6/16/2019)... ... June 15, 2019 , ... Lycotec Ltd, a Cambridge ... study on its new prebiotic, LycoBiotic™, which is 1,000 – 4,000 stronger than ... which were based on a proprietary composition of GA lycopene, specially developed for ...
Breaking Medicine Technology:
(Date:6/16/2019)... ... June 15, 2019 , ... All families go through tough times. When parents ... and lack of a support network, they may be unable to care for their ... the home and place them with a relative, familiar caregiver or foster family while ...
(Date:6/14/2019)... ... June 14, 2019 , ... ... Pink Bag Event® scheduled for Saturday, July 13th. UBCF is thrilled to return ... directly impacted by breast cancer. This second event was added after an overwhelming ...
(Date:6/13/2019)... ... June 13, 2019 , ... Endometriosis is a painful, inflammatory disease that occurs when ... , Painful periods , Heavy bleeding , Irregular menstruation , ... , Women’s Excellence uses the latest and newest treatment protocols in dealing with the ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... 30 Second Test (BL30SEC) has been accepted by the 2019 National Conference of ... Appendix N requirements. , The Charm BL30SEC test was validated by third ...
(Date:6/13/2019)... ... ... Hard money lenders like Monroe Funding Corporation are able to respond and approve ... If the documentation and collateral are immediately available, it’s possible to receive approval and ... with a traditional lender, which allows loans to be customized and adjusted based on ...
Breaking Medicine News(10 mins):